MIPASETAMAB

UNII:	DCI3L5GHC9
Formula:
Preferred Substance Name:	MIPASETAMAB
GSRS Full Record:	DCI3L5GHC9 i

2361055-48-1
1H12-GALNACN3
1H12-HAKB
IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TYROSINE KINASE AXL) (HUMAN-MUS MUSCULUS MONOCLONAL 1H12 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 1H12 .KAPPA.-CHAIN, DIMER, 302,302'-BIS(N-(O-2-(ACETYLAMINO)-6-AZIDO-2,6-DIDEOXY-.BETA.-D-GALACTOPYRANOSYL-(1->4)-O-(6-DEOXY-.ALPHA.-L-GALACTOPYRANOSYL-(1->6))-2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GLUCOPYRANOSYL)-L-ASPARAGINE)
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS AXL (AXL RECEPTOR TYROSINE KINASE, TYROSINE-PROTEIN KINASE RECEPTOR UFO)), HUMANIZED MONOCLONAL ANTIBODY (MIPASETAMAB)
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TYROSINE-PROTEIN KINASE RECEPTOR UFO (AXL ONCOGENE; EC=2.7.10.1)); HUMANIZED MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HUMANIZED (1-451) (VH HUMANIZED (HOMO SAPIENS IGHV3-30*03 (93%)-(IGHD)-IGHJ4*01 (92%)) (8.8.15) (1-122) HOMO SAPIENS IGHG1*03 (CH1(R97>K(219)), CH3(K107>DEL(452))) (123-451)), (225-215')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HUMANIZED (1'-215') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3-11*01 (84%)-IGKJ4*01 (91%))(7.3.9) (1'-108')-HOMO SAPIENS IGKC*01 (109'-215')); DIMER (231-231'':234-234'')-BISDISULFIDE, PRODUCED IN CHINESE CHO CELLS, GLYCOFORM ALFA
MIPASETAMAB [INN]
MIPASETAMAB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MIPASETAMAB

Synonyms and Mappings

Resources